Brainstem facilitations and descending serotonergic controls contribute to visceral nociception but not pregabalin analgesia in rats  by Sikandar, Shafaq et al.
B
v
S
D
h





a
A
R
R
A
K
V
R
V
5
P
1
s
a
v
a
t
t
[
r
h
o
u
0
hNeuroscience Letters 519 (2012) 31– 36
Contents lists available at SciVerse ScienceDirect
Neuroscience  Letters
jou rn al h om epage: www.elsev ier .com/ locate /neule t
rainstem  facilitations  and  descending  serotonergic  controls  contribute  to
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 i  g  h  l  i g  h  t  s
Descending  5-HT3 receptor-mediated  controls  are  pro-nociceptive  in  visceral  pain.
Some  -opioid  receptor-expressing  RVM  cells,  putative  ON-cells,  are  serotonergic.
Putative  RVM  ON-cells  mediate  basal  visceral  pain  responses  in  the  CRD  model.
Pregabalin  inhibits  evoked  visceral  pain  in rats  with  ablated  RVM  ON-cells.
State-dependent  pregabalin  analgesia  in neuropathy  does not  apply  to visceral  pain.
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a  b  s  t  r  a  c  t
Pro-nociceptive  ON-cells  in  the rostral  ventromedial  medulla  (RVM)  facilitate  nociceptive  processing  and
contribute  to  descending  serotonergic  controls.  We  use  RVM  injections  of  neurotoxic  dermorphin-saporin
(Derm-SAP)  in rats  to evaluate  the role  of  putative  ON-cells,  or  -opioid  receptor-expressing  (MOR)  neu-
rones,  in visceral  pain  processing.  Our  immunohistochemistry  shows  that  intra-RVM  Derm-SAP  locally
ablates  a substantial  proportion  of  MOR  and  serotonergic  cells.  Given  the  co-localization  of these  neuronal
markers,  some  RVM  ON-cells  are  serotonergic.  We  measure  visceromotor  responses  in  the  colorectal  dis-ostral  ventromedial medulla (RVM)
isceromotor response (VMR)
-HT
regabalin
tension  (CRD)  model  in control  and  Derm-SAP  rats, and using  the  5-HT3 receptor  antagonist  ondansetron,
we  demonstrate  pro-nociceptive  serotonergic  modulation  of  visceral  nociception  and  a  facilitatory  drive
from  RVM  MOR  cells.  The  2 calcium  channel  ligand  pregabalin  produces  state-dependent  analgesia
in  neuropathy  and  osteoarthritis  models  relating  to  injury-speciﬁc  interactions  with  serotonergic  facil-
itations  from  RVM  MOR  cells.  Although  RVM MOR  cells  mediate  noxious  mechanical  visceral  input,  we
 is no
.show  that  their  presence
. Introduction
The rostral ventromedial medulla (RVM) of the caudal brain
tem engages descending facilitatory and inhibitory pathways to
lter spinal nociceptive processing [28]. Brainstem modulation of
isceral pain responses in the colorectal distension (CRD) model of
cute visceral pain is well established and RVM descending projec-
ions provide a primary source of spinal serotonin (5-HT) [5,10].
Several  studies demonstrate serotonergic facilitatory modula-
ion onto the spinal cord through 5-HT3 receptors in neuropathic
17], inﬂammatory [16] and visceral pain models [22]. The 5-HT3
eceptor antagonist ondansetron reduces the excitability of dorsal
orn neurones [7]. Here, we pharmacologically investigate the role
f brainstem descending serotonergic modulation in visceral pain
sing the CRD model and ondansetron.
∗ Corresponding author. Tel.: +44 020 7679 3737; fax: +44 020 7679 7298.
E-mail address: shafaq.sikandar@ucl.ac.uk (S. Sikandar).
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Open access under CC BY license.t  a permissive  factor  for pregabalin  analgesia  in  acute  visceral  pain.
© 2012 Elsevier Ireland Ltd. 
RVM neurones are classiﬁed ON, OFF and NEUTRAL based
upon ﬁring patterns following noxious somatic stimulation; ON-
cells increase ﬁring immediately before a nocifensive response
[9]. However, RVM neurones do not always respond in the same
direction to visceral and cutaneous stimulation [5,19]. RVM ON-
cells are directly hyperpolarised by -opioids, thus referred to
as MOR  cells here [9]. Opioidergic sensitivity and the neuro-
toxin saporin allows for site-speciﬁc ablation of putative RVM
ON-cells [15]. Following conjugation with the MOR  agonist der-
morphin, GPCR-internalization of saporin causes apoptotic cell
death, whereas saporin alone has limited intracellular access and
thus minimal toxicity [4]. Furthermore, a signiﬁcant proportion of
spinally-projecting -opioid-responsive neurones are serotonergic
[11,20,24], and so it is likely that some ON-cells are serotonergic.
Targeted Derm-SAP ablation has previously demonstrated a
pro-nociceptive role of RVM MOR  cells in neuropathy and pancre-
Open access under CC BY licenseatitis [15,22,23] and a key permissive role of these cells and 5-HT3
receptor-mediated descending facilitations in the analgesic efﬁ-
cacy of pregabalin using somatic stimuli [3]. A recent study reports
subcortical sites of pregabalin action in visceral pain [13]. We  use
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ntra-RVM Derm-SAP to evaluate the role of putative RVM ON-cells
n visceral pain responses and whether these cells also exert a per-
issive action on pregabalin analgesia in visceral pain. Thus, this
tudy provides an anatomical and pharmacological substrate for
xploring modulation of visceral pain responses mediated by the
rainstem.
. Materials and methods
All  studies used male Sprague Dawley rats supplied by Biolog-
cal Services (University College London, UK). All procedures were
pproved by Home Ofﬁce (UK) and in agreement with IASP guide-
ines [29].
.1.  Electromyography recordings
Rats (250–300 g) were maintained on anaesthesia at 1% (v/v)
soﬂourane in a mixture of N2O (66%, v/v) and 02 (33%) through a
racheal cannula. An electromyography (EMG) electrode was sown
nto the right external oblique muscle and rats were secured to a
tereotaxic frame with a heating blanket to maintain a core tem-
erature of 37 ◦C. CRDs were produced by manually inﬂating a
olorectal balloon and a pressure ampliﬁer measured degree of
nﬂation in mmHg  [19]. The electrode was connected to a Neu-
olog system with a 1401 interface and Spike2 software (Cambridge
lectronic Design, UK). Filtered signals from muscle activity were
ntegrated (NL703 Module, Digitimer Limited, UK) and measured
s visceromotor responses (VMR).
The protocol for CRD administration was carried out as previ-
usly described [19]. 30 mmHg  was considered the cut-off between
ow- and high-threshold stimulation [12]. Once control EMG  values
ere obtained for distensions from 10 mmHg  to 80 mmHg (inte-
rated EMG  values did not differ more than 15% from each other),
 drug was administered (pregabalin, 30 mg/kg s.c.; ondansetron,
0 g in 25 l i.t. injected into L6-S1 intervertabrae space). Series
f distensions were performed and VMR  recorded 20 and 60 min
fter drug administration.
To  produce visceral hyperalgesia, mustard oil (0.25% in 1 ml  min-
ral oil) was applied intra-anally in the area occupied by the CRD
alloon, after control distensions. Thirty minutes were allowed for
yperalgesia to develop. Drug was administered 10 min  after mus-
ard oil (MO) so VMR  was recorded 30 and 70 min  after mustard
il application (corresponding to 20 and 60 min  after drug admin-
stration).
.2. Intra-RVM injections
Rats  (130 g) were anaesthetized with ketamine hydrochloride
60 mg/kg i.p.) and medetomidine hydrochloride (0.5 mg/kg i.p.).
nimals were secured to a stereotaxic frame and saporin or cyto-
oxic dermorphin-saporin (3 pmol in 1 l; Advanced Targeting
ystems, San Diego, CA) was injected into the RVM (0.0 mm medi-
lateral, 8.5–9.5 mm caudal from bregma, 9.0 mm dorsal from the
ura matter). Atipamezole hydrochloride (1 mg/kg s.c.) was  used to
everse anaesthesia. Rats were housed in cages under a 12-h alter-
ating light/dark cycle with ad libitum access to food and water. 28
ays were allowed for full cytotoxicity [15] before use in immuno-
istochemistry and EMG recordings.
.3. Immunohistochemistry
Rats were anaesthetized with pentobarbitone sodium (200 mg
.p.; Merial Animal Health Ltd., UK) and transcardially perfused
ith 300 ml  saline (0.9%, w/v) with heparin (5000 IU/l saline; LEO
aboratories, UK) and 300 ml  of 4% paraformaldehyde (VWR, UK)
n 0.6 M phosphate buffer solution (PBS). The spinal cord andLetters 519 (2012) 31– 36
hindbrain  were removed. Tissue was  post-ﬁxed and stored in a cry-
oprotectant solution of 30% (w/v) sucrose in 0.1 M PBS and 0.01%
(w/v) sodium azide (Sigma Aldrich, UK) for 3 days. RVM tissue was
collected serially in 40 m sections.
RVM sections were double-labelled for tryptophan hydroxylase
(TPH, the catalyst for serotonin synthesis as a marker of 5-HT) and
MOR. For MOR  staining, a rabbit polycolonal -opioid receptor pri-
mary antibody (1:10,000 TTBS; Neuromics, MN,  USA, RA10104) was
used with tyramide signal ampliﬁcation (TSA, Perkin Elmer, USA)
and the avidin biotin labelled complex (ABC Elite, Vector Laborato-
ries), followed by incubation with ﬂuorescein isothiocyanate (FITC,
1.67:1000 TTBS). Sections were then incubated with mouse mon-
oclonal anti-TPH primary antibody (1:1000 TTBS; Sigma–Aldrich,
UK, T0678) and ﬂuorescent Alexa Red ﬂuorescent (Alexa Red 594,
1:500 TTBS; Invitrogen, UK). Every third RVM section with on-
target injection sites was analysed using a ﬂuorescence microscope
at 10× magniﬁcation with appropriate wavelengths. Regions for
immunopositive cell analysis were delineated with reference to the
rat brain atlas and restricted to 10.5–11.5 mm caudal from bregma
[14].
2.4. Statistical analysis
Integrated  EMG  values with subtracted baselines were nor-
malized for each animal to mean controls EMG.  Normalized
EMG data was evaluated for normal distribution and eligibility
for ANOVA analysis with both the Kolmogorov–Smirnov (with
Dallal–Wilkinson–Lilliefor P value) and the D’Agostino and Pearson
omnibus normality tests. A two-way ANOVA with repeated mea-
sures and Bonferroni post-tests was  used to determine signiﬁcant
changes in VMR  throughout the range of CRD pressures between
drug time-points. A one-way ANOVA with Bonferroni post-tests
was used for area-under-curve comparisons.
Immunohistochemistry analysis was blinded using tissue from
4 rats per group (naïve, SAP and Derm-SAP) and 3 sections per ani-
mal. Templates for regions for immunopositive cell analysis were
delineated for quantifying total number MOR  and TPH immunopos-
itive cells. A one-way ANOVA with Bonferroni post-tests was used
to determine the difference between RVM cell counts of naïve, SAP
and Derm-SAP rats.
Statistical  signiﬁcance for all analysis was set at (*) P < 0.05, (**)
P < 0.01 and (***) P < 0.001 and data presented as mean ± SEM.
3.  Results
3.1. Serotonergic modulation of visceromotor responses
Control visceromotor responses (VMR) prior to drug adminis-
tration were clearly graded with increasing CRD pressures from
10 mmHg to 80 mmHg. Effects of spinal ondansetron, a 5-HT3
antagonist, were measured at 20 and 60 min. Ondansetron reduced
VMR at noxious CRD pressures (70–80 mmHg), revealing a role
for 5-HT3 receptor-mediated facilitatory modulation of nocicep-
tive VMR  (Fig. 1A; time variable F[2,80] = 11.93, P < 0.0001; pressure
variable F[7,80] = 10.28, P < 0.0001). Overall VMR  comparisons
illustrate rapid onset of ondansetron inhibition 20 min  after its
administration (Fig. 1B ﬁrst three bars; F[2,15] = 18.48, P < 0.0001).
Intracolonic mustard oil produces a transient visceral hyperal-
gesia where VMR  are signiﬁcantly potentiated in a time-dependent
manner, peaking at 30 min after mustard oil application, with
recovery of VMR  to control responses 70 min  after mustard oil
application (Fig. 1B middle three bars; F[2,15] = 36.75, P < 0.0001).
Ondansetron blocks this VMR  potentiation (last three bars;
F[2,15] = 13.09, P < 0.0001).
S. Sikandar et al. / Neuroscience 
Fig. 1. Intrathecal ondansetron reduces VMR  evoked by noxious CRD and pre-
vents development of visceral hyperalgesia induced by intracolonic mustard oil.
(A) VMR  evoked by a range of innocuous to noxious CRD pressures before and after
ondansetron administration (n = 6; *P < 0.05, **P < 0.01 control vs. 60 min). (B) Col-
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iective area-under-curve data of rats given ondansetron (OND; n = 6), intracolonic
ustard  oil (MO; n = 8), and intracolonic mustard oil and ondansetron (MO  + OND;
 = 6) (*P < 0.05, **P < 0.01, ***P < 0.001).
.2. Cytotoxic and visceromotor effects of intra-RVM Derm-SAP
njections
Derm-SAP treatment signiﬁcantly reduces RVM MOR  cell counts
ompared to control SAP or naïve rats (Fig. 2A and B; F[2,9] = 19,
 < 0.0001). Some RVM MOR  cells also express TPH immunore-
ctivity, a marker for 5-HT (Fig. 2D). Thus, Derm-SAP treatment
lso signiﬁcantly reduces TPH+ RVM cell counts (Fig. 2A and C;
[2,9] = 11.01, P < 0.0001). Importantly, there is no signiﬁcant dif-
erence in MOR  or TPH expression between naïve and SAP groups.
VMR  of Derm-SAP rats is graded with increasing CRD pressures,
ut lower than overall VMR  of naïve and SAP rats evoked at noxious
ressures, signiﬁcantly at 40 and 60 mmHg  (Fig. 3; time vari-
ble F[2,80] = 11.93, P < 0.0001; pressure variable F[7,80] = 10.28,
 < 0.0001). Also note the lower control VMR of Derm-SAP rats
Fig. 4A controls; F[2,11] = 6.80, P < 0.01).
.3.  Pregabalin modulation of visceromotor responses in acute
ain  and visceral hyperalgesia following Derm-SAP treatment
Systemic pregabalin (30 mg/kg s.c.) inhibits VMR  consistently
n naïve rats (F[2,11] = 12.25, P < 0.0001), SAP rats (F[2,11] = 6.081,Letters 519 (2012) 31– 36 33
P  < 0.001) and Derm-SAP rats (F[2,11] = 50.83, P < 0.0001), irrespec-
tive of the basal levels of activity (Fig. 4A). Systemic pregabalin
inhibits VMR  evoked by noxious CRD pressures in Derm-SAP
rats, signiﬁcantly at 60–80 mmHg  CRD (Fig. 4B; time vari-
able F[2,80] = 26.42, P < 0.0001; pressure variable F[7,80] = 15.51,
P < 0.0001).
Visceral hyperalgesia is produced by intracolonic mustard oil
in all groups, which is blocked by systemic pregabalin (Fig. 4C;
Derm-SAP rats (F[4,3] = 16.96, P < 0.0001); naïve rats (F[4,3] = 24.86,
P < 0.0001); SAP rats (F[4,3] = 9.731, P < 0.01)). Pregabalin contin-
ues to inhibit VMR  60 min  after administration, corresponding to
70 min  after mustard oil application (when VMR  regains control
levels in rats only treated with mustard oil and no modulatory
drug).
4. Discussion
We  used a receptor-speciﬁc antagonist to demonstrate a pro-
nociceptive role of spinal 5-HT3 receptors in the CRD model of
acute visceral pain. The Derm-SAP ablation technique revealed
a role of RVM ON-cells (MOR neurones) in regulating visceral
pain processing, but not the analgesic efﬁcacy of pregabalin. This
study highlights the role of brainstem modulation of visceral pain
responses and reveals a lack of state-dependence for pregabalin
analgesia in acute visceral pain.
4.1. Intra-RVM Derm-SAP ablations include serotonergic ON-cells
We  established that intra-RVM Derm-SAP effectively ablates a
substantial proportion of MOR  cells and a proportion of serotoner-
gic cells in the RVM. The parallel reduction in labelling for these
markers and their co-localization suggests that some MOR  RVM
cells are serotonergic. Other reports of signiﬁcant proportions of
spinally-projecting -opioidergic RVM neurones with serotoner-
gic immunoreactivity support our ﬁndings [11,20,24]. Indeed, we
refer to MOR  cells as putative ON-cells by deﬁnition of -receptor
expression, not neuronal ﬁring [9]. The idea that ON-cells are sero-
tonergic is conﬂicted by some reports suggesting that serotonergic
neurones are contained as one physiological class in the RVM [6].
However, these reports do not conﬁrm that ON-cells are not seroto-
nergic and discrepancies may  also be attributed to a small number
of cells sampled, which is ultimately not representative of the het-
erogeneous RVM population [11,27].
4.2. RVM ON-cells and serotonergic descending facilitations in
visceral  pain
Robust  inhibitory effects of ondansetron in our study clearly
argue for pro-nociceptive serotonergic modulation of visceral
pain. The majority of spinal 5-HT arises from descending RVM
projections [10] – a pro-nociceptive system in neuropathy and
inﬂammation [25]. We  have shown that a proportion of RVM MOR
cells are serotonergic, and further demonstrated a facilitatory role
of these cells in acute visceral nociception, given that intra-RVM
Derm-SAP inhibits full expression of basal visceral pain responses.
Putative RVM ON-cells are thought to infer selectivity in
modulating spinal sensory transmission of noxious stimuli with-
out affecting normal central processing of low-intensity input,
although this may  change after neuropathy [3]. This is likely related
to the preferential expression of 5-HT3 receptors on nerve ter-
minals of small-diameter primary afferent ﬁbres [26]. Indeed,
we show that 5-HT3 receptor blockade selectively reduces VMR
evoked by noxious CRD pressures. We  also ﬁnd that intra-RVM
Derm-SAP produces lower basal VMR, signiﬁcantly reduced in the
noxious range of CRD pressures compared to control rats. Inacti-
vating the RVM with lignocaine or transecting the spinal cord also
34 S.  Sikandar et al. / Neuroscience Letters 519 (2012) 31– 36
Fig. 2. Reduction of RVM MOR  and TPH immunoreactivity in Derm-SAP rats. (A) Photomicrographs of representative RVM sections from SAP and Derm-SAP rats for MOR
immunoreactivity (A1; labelled neurones in green) and TPH immunoreactivity (A2; labelled neurones in red). (B) MOR-expressing cell count in RVM sections from naïve,
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cAP  and Derm-SAP rats (***P < 0.001). (C) TPH-positive cell count in RVM sections f
ection  showing co-localization for TPH (red) and MOR  (green) immunoreactivity (
electively reduces mechanical hypersensitivities in neuropathic
nimals [3,21]. These ﬁndings reinforce a sub-modality speciﬁcity
f brainstem regulation and response to noxious mechanical stim-
li.
We use intracolonic mustard oil as a model of transient vis-
eral hyperalgesia. In Derm-SAP rats pre-treated with intracolonicaïve, SAP and Derm-SAP rats (**P < 0.01). (D) Confocal photomicrograph of an RVM
double-labelled neurones indicated by arrows).
mustard  oil, a transient enhancement of VMR  develops similar
to control rats. Although we  observe a partial loss in coding of
basal VMR  in Derm-SAP rats, this reduction in facilitatory drive
from RVM ON-cells following Derm-SAP treatment is not sufﬁcient
to attenuate the development of central hypersensitivity dur-
ing colonic inﬂammation. Similarly, Derm-SAP rats show normal
S. Sikandar et al. / Neuroscience 
Fig. 3. Reduction of basal VMR  in Derm-SAP rats. Control VMR  of naïve (n = 6),
SAP (n = 8) and Derm-SAP rats (n = 8; **P < 0.01 naïve vs. Derm-SAP, ˆP < 0.05 SAP
vs.  Derm-SAP).
Fig. 4. Pregabalin analgesia in Derm-SAP rats. (A) Overall VMR  following systemic pregab
to the control VMR  of naïve rats (*P < 0.05, **P < 0.01, ***P < 0.001). Note the signiﬁcant red
evoked by a range of innocuous to noxious CRD pressures before and after pregabalin admi
ˆˆˆP < 0.001 control vs. 60 min). (C) Collective data of naïve, SAP and Derm-SAP rats with 
naïve, SAP and Derm-SAP rats with pregabalin and intracolonic mustard oil (naïve MO + PG
to the controls of naïve rats. Signiﬁcant differences are only shown relative to 30 min  afte
(*P < 0.05, ***P < 0.001).Letters 519 (2012) 31– 36 35
hypersensitivity in early stages of chronic pain development [23].
Thus RVM MOR  cells provide descending pro-nociceptive controls
on acute visceral pain responses without signiﬁcantly affecting the
development of hypersensitivities in acute inﬂammation. Sufﬁcient
facilitatory drive must be retained in Derm-SAP rats – from spared
RVM MOR  cells or from other central neurones – to contribute to
VMR evoked by noxious CRD and contribute to potentiated VMR
in our acute visceral hyperalgesia model. An added complication
is the potential facilitatory role of other RVM neurones (OFF- and
NEUTRAL-cells) in visceral processing [5,19].
4.3. Pregabalin analgesia in acute visceral pain vs.
state-dependent actions of pregabalin in neuropathyPregabalin binds with the ubiquitous 2 subunit of voltage-
gated calcium channels to impair calcium channel trafﬁcking [2].
Its analgesic actions in neuropathy and osteoarthritis are thought
to rely on permissive factors – these include a pathological state
alin in naïve (n = 6), SAP (n = 6) and Derm-SAP rats (n = 6) with controls normalized
uction of control VMR  in Derm-SAP rats compared to naïve and SAP rats. (B) VMR
nistration in Derm-SAP rats (n = 6; ***P < 0.001 control vs. 20 min, ˆP < 0.05, ˆˆP < 0.01,
intracolonic mustard oil (naïve MO, n = 8; SAP MO,  n = 8; Derm-SAP MO,  n = 8) and
B, n = 7; SAP MO + PGB, n = 8; Derm-SAP MO + PGB, n = 8) – all  with VMR  normalized
r mustard oil application to illustrate pregabalin inhibition of visceral hyperalgesia
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nd injury-speciﬁc interactions with descending 5-HT3-receptor
ediated facilitations form the brainstem [3,16]. Indeed, intra-
VM Derm-SAP has previously demonstrated the permissive role
f these ON-cells in pregabalin analgesia in neuropathy [3]. On the
ther hand, pregabalin analgesia has recently been demonstrated
n a model of opioid-induced hyperalgesia where pathophysiology
s lacking [1], and other studies report analgesic effects of prega-
alin in acute visceral pain [18,19]. We  also show here that systemic
regabalin signiﬁcantly reduces evoked visceral pain in Derm-SAP
ats in normal conditions and during transient visceral hyperal-
esia, thereby dismissing any permissive role of putative RVM
N-cells in the analgesic efﬁcacy of pregabalin in acute visceral pain
unlike neuropathy and osteoarthritis conditions). As discussed
bove, we cannot exclude the possibility of actions of pregabalin
n other RVM neurones or locus coeruleus neurones in producing
nalgesia [8].
We  have recently demonstrated an activity-dependent role of
VM neurones in VMR  and a sensitivity of RVM ON-cells to prega-
alin [19]. Here, the lack of effect on acute visceral pain responses
nd development of visceral hyperalgesia following ablation of
VM MOR  cells could be explained by the lack of correspondence
n RVM cell activity to visceral and somatic stimulation [5,19].
ccordingly, all three RVM cell types can behave as ON-cells when
isceral stimuli are used to provide a permissive facilitatory drive
hat allows pregabalin actions. Similar explanations could underlie
he resistance of mustard oil-induced hyperalgesia to the ablative
echnique.
. Conclusions
We  show that 5-HT3 receptor-mediated descending facilitation
odulates acute visceral pain. We  also use Derm-SAP ablation
f putative RVM ON-cells to reveal their role in regulating basal
isceral pain responses. Nevertheless, descending facilitations
ediated by these cells is not necessary for the development of
isceral hyperalgesia or for the analgesic efﬁcacy of pregabalin.
he latter contradicts ﬁndings in some somatic pain models, so the
echanisms of action of pregabalin must differ between somatic
nd visceral pain states. However, a shared interaction may  be the
hift in the balance of descending modulation from the brainstem,
here enhanced descending facilitatory controls (or a reduction in
nhibitory inﬂuences) produced by acute visceral stimuli produce a
ermissive physiological state of central excitability for pregabalin
o exert inhibitory actions.
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